Although this did not reach statistical significance—most likely due to the small number of mutation-positive cases—the distribution is consistent with the established biology of papillary thyroid carcinoma, in which BRAF mutations predominantly occur in morphologically suspicious nodules [64,65]. Here, BRAF is linked to differentiated thyroid carcinoma.